Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07417241 | SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study | not yet recruiting | Phase 2 | 100 | Peking University Cancer Hospital & InstituteOTHER | 0 | Feb 18, 2026 | clinicaltrials |
| NCT07411651 | Confirmation of the Link Between Endocrine Disruptors Exposure and Breast Cancer and Identification of Biological Response Biomarkers(EXPOSAL) | not yet recruiting | N/A | 42 | Poitiers University HospitalOTHER |
| 1 |
| Feb 17, 2026 |
| clinicaltrials |
| NCT07415200 | Pedicled Lateral Chest Wall Lymph-Adipofascial Flap to Prevent Arm Lymphedema After Breast Cancer Surgery(LAF-ALND) | not yet recruiting | N/A | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07406165 | Nonpharmacological Management of Pain and Fear During Hormone Injection in Breast Cancer Patients | not yet recruiting | N/A | 99 | Inonu UniversityOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT07409948 | Multicomponent Care for Aromatase Inhibitor-Related Musculoskeletal Symptoms(AIMSS-CARE) | not yet recruiting | N/A | 88 | Addis Ababa UniversityOTHER | 0 | Feb 13, 2026 | clinicaltrials |
| NCT07410234 | Phase II Exploratory Study of Toripalimab Combined With SBRT in HER2-Negative Breast Cancer Patients With Insensitivity to Neoadjuvant Chemotherapy | not yet recruiting | Phase 2 | 110 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Feb 13, 2026 | clinicaltrials |
| NCT07406542 | A Phase III Study of SYS6010 Versus Chemotherapy in HER2-Negative, EGFR-Positive Recurrent or Metastatic Breast Cancer | not yet recruiting | Phase 3 | 400 | CSPC Megalith Biopharmaceutical Co.,Ltd.INDUSTRY | 0 | Feb 12, 2026 | clinicaltrials |
| NCT07406594 | Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer(MICRO-VERZ) | not yet recruiting | N/A | 12 | University of Vermont Medical CenterOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07406789 | Phase II, Prospective, Randomized, Proof-of-concept Study to Evaluate the Effects of a Personalized Dietary Intervention in Women With Advanced Gynecologic or Breast Tumors Treated With Antibody-Drug Conjugates (ADCs).(LUMInova) | not yet recruiting | Phase 2 | 100 | TNC Nutrición Terapéutica S.L.OTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07407517 | Adjuvant Intensification for LAR(POLARIS) | not yet recruiting | Phase 3 | 904 | Fudan UniversityOTHER | 0 | Feb 12, 2026 | clinicaltrials |
| NCT07385365 | A Study of Postoperative Regional Nodal Radiotherapy in Intermediate-risk Breast Cancer | not yet recruiting | Phase 3 | 3,142 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT07392424 | BreastCancerPEP: A Six-Month Online Empowerment Program to Improve Mental and Physical Health in Women With Breast Cancer | not yet recruiting | N/A | 160 | Gabriela IlieOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT07393321 | A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer | not yet recruiting | Phase 3 | 210 | Nanjing Chia-tai Tianqing PharmaceuticalINDUSTRY | 0 | Feb 6, 2026 | clinicaltrials |
| NCT07389200 | Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer | not yet recruiting | — | 400 | Hao XuOTHER | 0 | Feb 5, 2026 | clinicaltrials |
| NCT07387861 | PI3K Pathway Activation Markers in ER-Positive, HER2-Negative Breast Cancer: A Clinicopathologic Study(p-AKT p-S6) | not yet recruiting | — | 70 | Assiut UniversityOTHER | 0 | Feb 4, 2026 | clinicaltrials |
| NCT07382687 | Famitinib Combined With SHR-A1811, Versus SHR-A1811 for CDK4/6 Inhibitors-resistent Advanced HR+/HER2- Breast Cancer With SNF4 Subtype | not yet recruiting | Phase 3 | 248 | Fudan UniversityOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07380230 | Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients | not yet recruiting | N/A | 60 | LI FENGOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07275203 | Concordance of the Biology of Primary Breast Carcinoma and the Biology of Recurrence . | not yet recruiting | — | 200 | Sohag UniversityOTHER | 0 | Jan 29, 2026 | clinicaltrials |
| NCT07370506 | Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients | not yet recruiting | Phase 1 / Phase 2 | 36 | Tanta UniversityOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07371702 | PERsonalized Mammographic Screening in Norway(PERMS) | not yet recruiting | — | 3,000 | Norwegian Institute of Public HealthOTHER_GOV | 0 | Jan 29, 2026 | clinicaltrials |
| NCT07367178 | Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast Cancer(SATROPIN) | not yet recruiting | Phase 2 | 30 | MedSIROTHER | 0 | Jan 28, 2026 | clinicaltrials |
| NCT07368543 | Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast Cancer(STORM) | not yet recruiting | Phase 2 | 216 | Fudan UniversityOTHER | 0 | Jan 28, 2026 | clinicaltrials |
| NCT07372144 | Creatine and Cognitive Health in Patients With Early-stage Breast Cancer During and After Chemotherapy Treatment(IARA) | not yet recruiting | Phase 3 | 227 | D'Or Institute for Research and EducationOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT07372339 | Comparison of Breast Sensory Recovery Between Conventional and Endoscopic Nipple-Sparing Mastectomy Combined With Prepectoral Implant Reconstruction | not yet recruiting | N/A | 170 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Jan 28, 2026 | clinicaltrials |
| NCT07374198 | Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Mild-to-Severe Depression | not yet recruiting | N/A | 142 | Chinese PLA General HospitalOTHER | 0 | Jan 28, 2026 | clinicaltrials |
| NCT07374211 | Effect of Esketamine on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Severe Depression | not yet recruiting | N/A | 242 | Chinese PLA General HospitalOTHER | 0 | Jan 28, 2026 | clinicaltrials |
| NCT07367542 | Effect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery | not yet recruiting | N/A | 218 | Chinese PLA General HospitalOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT07370571 | NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE)(OXIGENATE) | not yet recruiting | — | 827 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 0 | Jan 27, 2026 | clinicaltrials |
| NCT07366840 | RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure(BRIGHT) | not yet recruiting | Phase 2 / Phase 3 | 268 | Fudan UniversityOTHER | 0 | Jan 26, 2026 | clinicaltrials |
| NCT07367711 | The Influence of Chemotherapy on Position Sense(ProprioCIPN) | not yet recruiting | — | 145 | KU LeuvenOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT06811454 | Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) | not yet recruiting | N/A | 76 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07364760 | The Effect of Group and Mobile Wellness Coaching Given to Women With Breast Cancer on the Disease | not yet recruiting | N/A | 124 | Saglik Bilimleri UniversitesiOTHER | 0 | Jan 23, 2026 | clinicaltrials |
| NCT07354490 | Accuracy of Sono-mammographic Features in Molecular Classification of Breast Cancer | not yet recruiting | — | 122 | Assiut UniversityOTHER | 0 | Jan 21, 2026 | clinicaltrials |
| NCT07355244 | Self-Affirmation Intervention After Mastectomy | not yet recruiting | N/A | 42 | Muş Alparslan UniversityOTHER | 0 | Jan 21, 2026 | clinicaltrials |
| NCT07344974 | Hand and Foot Bath for Taxane-Induced Peripheral Neurotoxicity | not yet recruiting | Phase 4 | 78 | Peking University Cancer Hospital & InstituteOTHER | 0 | Jan 20, 2026 | clinicaltrials |
| NCT07353437 | Fluzoparib as Adjuvant Treatment in Patients With Germline Homologous Recombination Repair (HRR) Mutated Primary Breast Cancer (Flamenco) | not yet recruiting | Phase 2 | 334 | Fudan UniversityOTHER | 0 | Jan 20, 2026 | clinicaltrials |
| NCT07313033 | [68]GA-FAPI-46 PET/CT for the Diagnosis of Metastatic Lesions in Patients With Lobular Breast Cancer (ICL).(FAPI-CL) | not yet recruiting | N/A | 45 | Hospices Civils de LyonOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT07348744 | The Effect of a Health Belief Model-Based Education Program on Breast Self-Examination Practice Behavior, Breast Cancer Fear, and Awareness Levels in Women: A Randomized Controlled Trial(KAU-BSE-RCT) | not yet recruiting | N/A | 76 | Kafkas UniversityOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT07344597 | Prospective Comparative Study of Hypofractionated Adjuvant Radiotherapy in 2 Virsus 3 Weeks in Breast Cancer | not yet recruiting | — | 70 | Salwa Shawky Bakeet AliOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT07345026 | Acellular Dermal Matrix(SureDerm BCS) in Breast-Conserving Surgery for Breast Cancer Patients | not yet recruiting | N/A | 116 | Seoul St. Mary's HospitalOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT07336771 | JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer | not yet recruiting | Phase 1 / Phase 2 | 60 | Jiangsu Alphamab Biopharmaceuticals Co., LtdINDUSTRY | 1 | Jan 13, 2026 | clinicaltrials |
| NCT07331740 | Development and Application of a Parenting Anxiety Intervention Program for Young and Middle-Aged Female Breast Cancer Patients | not yet recruiting | N/A | 20 | Shanghai University of Traditional Chinese MedicineOTHER | 0 | Jan 12, 2026 | clinicaltrials |
| NCT07317752 | Incidence of Dysgeusia in Breast Cancer Patients Undergoing Chemotherapy(GustiAmo) | not yet recruiting | — | 40 | Azienda Sanitaria Locale CN2 Alba-BraOTHER | 0 | Jan 5, 2026 | clinicaltrials |
| NCT07309887 | This Clinical Trial is a Retrospective, Multicenter Cohort Study Evaluating the Real-world Characteristics and Risk of Disease Recurrence in Hormone Receptor-positive, HER2-negative Early Breast Cancer.(PRIORITY) | not yet recruiting | — | 100,000 | Samsung Medical CenterOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07311122 | Endocrine Therapy Base on 21-gene RS(CUSTOM) | not yet recruiting | — | 4,000 | Gangnam Severance HospitalOTHER | 0 | Dec 30, 2025 | clinicaltrials |
| NCT07311317 | Cellular-Level Fluorescence Imaging for Intraoperative Margin Assessment in Breast Cancer(FLASH) | not yet recruiting | — | 165 | West China HospitalOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07307287 | SHR-A1811 Plus Pertuzumab as Neoadjuvant Therapy for Early or Locally Advanced HR-Positive HER2-Positive Breast Cancer: A Prospective, Open-Label, Phase II Study | not yet recruiting | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Dec 29, 2025 | clinicaltrials |
| NCT07305246 | Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer | not yet recruiting | Phase 2 | 120 | First Hospital of China Medical UniversityOTHER | 0 | Dec 26, 2025 | clinicaltrials |
| NCT07299409 | First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients. | not yet recruiting | Phase 2 | 24 | Nathalie LevasseurOTHER | 1 | Dec 23, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Feb 18, 2026source: clinicaltrials